|
Key Opinion Leaders are integral to the development, endorsement and therefore success of any pharmaceutical drug.
For any company attempting to commercialise a drug, healthy continuous relationships with key opinion leaders in relevant clinical areas can be an added bonus to the product’s overall marketing strategy.
Identifying relevant key opinion leaders, initiating contact with them and nurturing the relationships over the life cycle of the drug can be a challenging area for pharmaceutical companies. Customer relationship management is pivotal to enhancing these relationships.
Clouded in controversy, the integrity of the KOL-industry interaction and relationship development has been open to abuse with industry going above and beyond to influence what should be objective, scientific opinions of clinical experts. Regulation in the USA and in Europe is calling for transparency and openness to alleviate this, but how open should industry be?
The inaugural Key Opinion Leaders Europe conference is on 15th & 16th June 2009 in Munich.
Why should you attend this event?
The conference will address the following topics with individual pharmaceutical case studies, expert presentations from medical practise and industry, attendees will walk away with a comprehensive tool kit on:
- Definition of key opinion leaders
- Practical management of key opinion leaders
- How & when to interact with industry – for key opinion leaders
- Identifying relevant and emerging opinion leaders in your clinical area
- Best approach to initiating contact: assessing fair market value etc
- Various approaches to the building, maintaining and strategic management of key opinion leaders for optimal clinical development
- The issue of transparency? How open? What to be open about? The guidelines and how to be compliant? Best practise?
- Accessing key opinion leaders in Central & Eastern Europe
- Transparency tools and techniques used in pharmaceutical companies
- Impact of KOL management on the business
- Identified areas of development and what’s on the horizon for improved KOL management and interaction?
There will also be plenty of opportunity to take part in Question & answer sessions, panel debates and of course network with your peers during all the refreshment breaks!
Our expert speaker line-up also includes:
Dr Ernst Schilli & Gunnar Schroefel,Global Business Support- Customer Relationship Excellence, Bayer-Scering Pharma
Lisette Tiddens-Engwirda, Secretary General, Standing Committee European Doctors (CPME)
Dr Linda Harris, Assistant Vice President, Opinion Leader Relations, Wyeth USA
Dr Raimund Sterz, Medical Director, Abbott Laboratories
Dr Iain Macdougall, Professor of Nephrology, King's College, London
Neil Jones, Director, Branded Solutions, Medical Marketing Research International
Neil Kendle, Managing Director, Kendle Healthcare
Fred Eaton, Leader Fair Market Value Practise, Polaris Management Partners
Dr Ken O'Reilly, Global Medical Education, Vifor Pharma
Ales Kminek, Medicla Marketing Director, Astra Zeneca Czech Republic
David Cocker, Partner, mdcpartners
Who should attend?
The KOL London 2008 conference attracted the following professionals:
- Head of Customer Relationship Management, Bayer-Schering AG
- Director Scientific Communications, GlaxoSmithKline UK
- Head of Medical & Scientific Affairs, Boehringer Ingelheim
- Assistant Vice President, Opinion Leader Relations, Wyeth USA
- Professional Relations, Roche
- Associate Branding Director, Astellas Europe
- Manager Medical Affairs, Linde AG
- Marketing Director EMEA, Allergan
- Medical Director, Bayer
- Medical Director, Pfizer
- Associate Medical Director, Cilag Biotech
- Product Director, International Marketing, Shire Pharmaceuticals
- Director, Regional Medical Liaisons, Amgen Inc.
- Clinical Director, Astra Zeneca
- Vice President Global Sales & Marketing, Covidien
- New Product Manager, Global Marketing, Laboratorios Almirall S.A.
- Professional Relations Manager, Medical & Healthcare, Lundbeck
- Medical Marketing Manager, Genzyme Europe
If any of the above topics interest you or if you want to network with any of the above people, experiencing the same issues, then register now!
Venue details
Sophienstraße 28, D- 80333, München, Deutschland
Tel: + 49 895 44 555 0 Fax: + 49 89544 555 2000 www.charleshotel.de
The Charles Hotel's location in the heart of Munich, close to the historic square of Königsplatz, the old town and the superb shopping area, suits both business and leisure guests staying in Munich, yet its situation in the Botanischer Garten ( Old Botanical Gardens) means peace and tranquillity away from the city's bustle.
This luxury five star Munich hotel is custom built and has all the hallmarks of a Rocco Forte Hotel: individual design, elegant comfort, excellent levels of service, up-to-date corporate facilities and a top quality health club.
DIRECTIONS
Train Station:- the Hauptbahnhof main train station for metro and rail services is 300 metres from the hotel.
Airport: Franz Josef Strauss Airport is approximately 40 minutes / 35 km from the hotel.
SMi discounted Accommodation rates - Classic King Room 300 EURO per night
This rate is inclusive of VAT and service charges. A buffet breakfast is available for 28 EURO
If you wish to book accommodation from the allocation we have on hold, please contact the hotel directly on reservations.charles@roccofortecollection.com quoting "Key Opinion Leaders Europe"
|
Events Home Page
 logo.jpg)
